Literature DB >> 689746

Protective isolation and antimicrobial decontamination in patients with high susceptibility to infection. A prospective cooperative study of gnotobiotic care in acute leukaemia patients. III: The quality of isolation and decontamination.

J Dankert, W Gaus, H Gaya, D Krieger, G Linzenmeier, D van der Waaij.   

Abstract

In a cooperative study, the quality of protective isolation and of antibiotic decontamination of the digestive tract was studied in patients with acute leukaemia by (bio)-typing of Enterobacteriaceae species, Pseudomonas aeruginosa and Staphylococcus aureus isolated from oral washings and faecal samples. These samples were collected before and during treatment of 82 patients who were either isolated and decontaminated for which latter purposes a combination of neomycin, polymyxin, bacitracin and nystatin was used (group A); isolated without decontamination (Group B) or treated on the ward without decontamination (Group C). The results indicated that protective isolation had only been completely successful during the entire (remission induction) treatment period in one of the 32 patients in Group B. In Group A patients, who underwent antibiotic decontamination in addition, successful isolation was achieved in 57% of 28 patients. Successful antibiotic decontamination of the digestive tract for the entire treatment period as far as all potentially pathogenic species are concerned, was realized in 4 (14%) of the 28 patients of Group A. Bacteriologically confirmed infections occurred in 50% of Group A patients, in 59% Group B patients and in 64% of Group C patients. It is concluded that the quality of isolation had in general been insufficient but that it was improved by oral nonabsorbable antibiotics and, furthermore, that the antibiotic decontamination procedure also requires improvement.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 689746     DOI: 10.1007/BF01641908

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  15 in total

1.  ULTRA-CLEAN WARD FOR CANCER CHEMOTHERAPY.

Authors:  K D BAGSHAWE
Journal:  Br Med J       Date:  1964-10-03

2.  Protective isolation and antimicrobial decontamination in patients with high susceptibility to infection. A prospective cooperative study of gnotobiotic care in acute leukemia patients. I: clinical results.

Authors:  M Dietrich; W Gaus; J Vossen; D van der Waaij; F Wendt
Journal:  Infection       Date:  1977       Impact factor: 3.553

3.  Use of oral antibiotics in protected units environment: clinical effectiveness and role in the emergence of antibiotic-resistant strains.

Authors:  J Klastersky; L Debusscher; D Weerts; D Daneau
Journal:  Pathol Biol (Paris)       Date:  1974-01

4.  Gastrointestinal "sterilization" in the treatment of patients with acute leukemia.

Authors:  H D Preisler; I M Goldstein; E S Henderson
Journal:  Cancer       Date:  1970-11       Impact factor: 6.860

5.  Protected environments and prophylactic antibiotics. A prospective controlled study of their utility in the therapy of acute leukemia.

Authors:  A S Levine; S E Siegel; A D Schreiber; J Hauser; H Preisler; I M Goldstein; F Seidler; R Simon; S Perry; J E Bennett; E S Henderson
Journal:  N Engl J Med       Date:  1973-03-08       Impact factor: 91.245

6.  Pathogen-free isolation unit--three years' experience.

Authors:  M Schneider; L Schwarzenberg; J L Amiel; A Cattan; J R Schlumberger; M Hayat; F De Vassal; C Jasmin; C Rosenfeld; G Mathé
Journal:  Br Med J       Date:  1969-03-29

7.  Protocol for an evaluative study of the protective effect of isolation systems and decontamination in patients with high susceptibility to infection.

Authors: 
Journal:  Eur J Cancer       Date:  1972-08       Impact factor: 9.162

8.  Protected environment-prophylactic antibiotic program in the chemotherapy of acute leukemia.

Authors:  G P Bodey; E A Gehan; E J Freireich; E Frei
Journal:  Am J Med Sci       Date:  1971-09       Impact factor: 2.378

9.  A controlled study of isolation and endogenous microbial suppression in acute myelocytic leukemia patients.

Authors:  J W Yates; J F Holland
Journal:  Cancer       Date:  1973-12       Impact factor: 6.860

10.  Infection by the distribution of biotypes of enterobacteriacease species in leukaemic patients treated under ward conditions and in units for protective isolation in seven hospitals in Europe.

Authors:  D Van der Waaij; T M Tielemans-Speltie; A M De Roeck-Houben
Journal:  Infection       Date:  1977       Impact factor: 3.553

View more
  7 in total

1.  Laminar air flow versus barrier nursing in marrow transplant recipients.

Authors:  H K Mahmoud; U W Schaefer; F Schüning; C G Schmidt; M Bamberg; E Haralambie; G Linzenmeier; D Hantschke; H Grosse-Wilde; W Luboldt
Journal:  Blut       Date:  1984-11

2.  E.O.R.T.C. Gnotobiotic Project Group: a prospective cooperative study of antimicrobial decontamination in granulocytopenic patients. Comparison of two different methods.

Authors: 
Journal:  Infection       Date:  1982       Impact factor: 3.553

3.  The efficiency of strict reverse isolation and antimicrobial decontamination in remission induction therapy of acute leukemia.

Authors:  E Kurrle; S Bhaduri; H Heimpel; D Hoelzer; D Krieger; E Vanek; B Kubanek
Journal:  Blut       Date:  1980-03

4.  Infections after experimental cadaver bone marrow transplantation in beagle dogs. Transplantations with and without selective gastrointestinal decontamination.

Authors:  E Haralambie; A Schmidt-Weinmar
Journal:  Infection       Date:  1988       Impact factor: 3.553

5.  Bacteriological aspects of selective decontamination of the digestive tract as a method of infection prevention in granulocytopenic patients.

Authors:  H G de Vries-Hospers; D T Sleijfer; N H Mulder; D van der Waaij; H O Neiweg; H K van Saene
Journal:  Antimicrob Agents Chemother       Date:  1981-05       Impact factor: 5.191

6.  The dose at which neomycin and polymyxin B can be applied for selective decontamination of the digestive tract in mice.

Authors:  C H Emmelot; D van der Waaij
Journal:  J Hyg (Lond)       Date:  1980-06

7.  Prevention of infection in children with acute leukaemia. No major difference between total and selective bowel decontamination.

Authors:  N Muis; W A Kamps; J Dankert
Journal:  Support Care Cancer       Date:  1996-05       Impact factor: 3.603

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.